An Introduction to COVID-19
On 11 March 2020, the World Health Organization declared COVID-19 a pandemic. The impact on the medical community has been huge, not only on the front-line, but also for patients navigating treatment for neurological conditions during this unprecedented situation.
The touchNEUROLOGY expert faculty have been sharing their experiences and advice during this challenging time through video interviews and short articles.
Our supporting partners do not constitute an endorsement of the content on this page.
Amos Korczyn, CONy 2020 – Highlights from the President of CONy
touchNEUROLOGY were delighted to have the opportunity to speak with Amos Korczyn, Founder and President of CONy about his highlights of this year’s virtual meeting. Questions What were your personal highlights of CONy 2020? (0:05) Tell us about plans for CONy 2021 (4:43) Support: Interview and filming supported by Touch Medical Media Ltd. Disclosures: Founder […]
COVID-19 and the World Congress on Controversies in Neurology
European Neurological Review. 2020;15(1):9-10 DOI: https://doi.org/10.17925/ENR.2020.15.1.9
The World Congress on Controversies in Neurology (CONy) provides a platform for international experts to discuss and compare experiences. Its debate-style structure bridges the gap between the latest scientific advances and their dissemination and use. The congress has become a major annual event for members of the neurological community. As a result of the COVID-19 […]
Hannu Alho – Potential of Ondansetron in Alcohol Use Disorder (Part 2)
Professor Emeritus of Addiction Medicine, Hannu Alho (University of Helsinki, Finland) discusses the need for effective treatment options to manage alcohol use disorder, focusing on odansetron as a newly emerging possibility. Ondansetron is a specific 5HT3-receptor antagonist, which blocks 5HT3 receptors in the gastrointestinal tract and central nervous system, and has been used since the […]
Neurological Aspects of the COVID-19 Pandemic
European Neurological Review. 2020;15(1):13-7 DOI: https://doi.org/10.17925/ENR.2020.15.1.13
In the past 4 months, a novel coronavirus originating in Wuhan, China, SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), has affected more than 200 countries. As of mid-June 2020, there are over 7 million confirmed cases and more than 425,888 deaths worldwide caused by the novel coronavirus, although the numbers are likely to be higher […]
Bengt Winblad, EAN 2020 – Swedish Geriatric Neurologist Perspective on COVID-19
Always a pleasure to catch-up with Editorial Board member, Bengt Winblad (Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden), who chatted with us on several topics including his perspective on the COVID-19 pandemic as a Swedish geriatric neurologist. Question What are your thoughts on the COVID-19 pandemic as a Swedish geriatric neurologist? (0:05) Also see […]
Andrew Chan, EAN 2020 – COVID-19 and Multiple Sclerosis
Great to catch-up with Andrew Chan (Inselspital Bern, University Hospital, University of Bern, Bern, Switzerland), who discussed challenges posed to patient care by COVID-19, factors to consider around immunosuppression for patients with multiple sclerosis (MS) during the pandemic, as well his personal thoughts on exciting developments in MS therapy and the 1st Virtual EAN Congress. […]
Angelo Antonini, May 2020 – Neurological and Psychiatric Events in Patients with COVID-19
We caught up with our Editorial Board member, Angelo Antonini (University of Padova, Veneto, Italy), to discuss the neurological and psychiatric events that have been observed in patients with COVID-19, what could be done to prepare for these and if anything can be learnt from current experience. Questions 1. Could you tell us about the […]
K Ray Chaudhuri, EAN 2020 – Personalising Parkinson’s Treatment During the COVID-19 Pandemic
So pleased to have had an opportunity to catch-up with editorial board member, K Ray Chaudhuri (King’s Parkinson’s Centre, King’s College Hospital and Kings College London, UK), who shared his expert perspective on the clinical impact of COVID-19 on people with Parkinson’s disease. Questions 1. What treatment strategies should be implemented in patients with Parkinson’s […]
K Ray Chaudhuri, EAN 2020 – Clinical Impact of COVID-19 on People With Parkinson’s Disease
So pleased to have had an opportunity to catch-up with editorial board member, K Ray Chaudhuri (King’s Parkinson’s Centre, King’s College Hospital and Kings College London, UK), who shared his expert perspective on the clinical impact of COVID-19 on people with Parkinson’s disease. Question What is the clinical impact of COVID-19 on people with Parkinson’s […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!